Dr. Joshua K. Sabari and Dr. Daniel V. Araujo provide expert insights into genitourinary cancer updates from ASCO 2025.

Expert oncologists Dr. Joshua K. Sabari and Dr. Eric K. Singhi break down key updates and takeaways in lung cancer treatment following ASCO 2025.

GSK is putting the finishing touches on its case for antibody-drug conjugate Blenrep with a key progression-free survival ...

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- ...

Practitioners in each profession detail the speed of regulatory challenges and changes, emphasize the importance of keeping ...

Saudi Government and Seha Virtual Hospital selected Lunit INSIGHT CXR to detect respiratory diseases among millions of pilgrims, supporting Saudi Arabia's Vision 2030 healthcare strategy SEOUL ...